王友明 主任

E-mail：
現職
  • 高雄長庚紀念醫院 放射腫瘤部及質子暨放射治療中心 主任
  • 台灣放射腫瘤學會 理事
  • 國家實驗研究院 STB學者
  • 全民健康保險 醫藥審查專家
  • 中國人體健科會 質子重離子放療專委會 委員
  • 高雄長庚紀念醫院 副教授級主治醫師
  • 中國廈門市 主任級醫師
學歷
  • 嘉義縣私立協同中學 畢業
  • 國立陽明大學 醫學系 醫學士
經歷
  • 國立陽明大學 吉他社 社長
  • 台北市 木船民歌西餐廳 歌手
  • 台北市立內湖高工 吉他社 指導老師
  • 高雄榮民總醫院 實習醫師
  • 高雄長庚紀念醫院 放射腫瘤科 住院醫師、總醫師
  • 高雄長庚紀念醫院 放射腫瘤科 主治醫師
  • 美國Stanford大學及醫學中心 訪問學者
  • 高雄長庚紀念醫院 副主任
專長
  • 質子治療、三維導航強度調控質子治療
  • 鼻咽癌、頭頸癌、食道癌、胸腔腫瘤、兒童腫瘤、腦瘤
  • 立體定位放射手術、電腦刀
  • 生理訊號分析
工作職責
  • 癌症之放射治療
專科學會
  • 台灣放射腫瘤學會
  • 台灣頭頸部腫瘤醫學會
  • 美國放射腫瘤學會
  • 歐洲放射腫瘤學會
論文著述(第一或指導作者)
  • 學術論文發表逾50篇
  • 1. Liu CM, Cheng JY, Lin YH, Chen CS, Wang YM*.: Elective upper-neck versus whole-neck irradiation of the uninvolved neck in patients with nasopharyngeal carcinoma. Lancet Oncol. 2022 Jun;23(6): e240. (SCI; IF=41.316; ONCOLOGY 5/242)
  • 2. Huang TT, Chou SY, Lin YH, Li SH, Chen YH, Lu HI, Lo CM, Fang FM, Chiu YC, Chou YP, Wang YM*.: The Impact of Weight Loss during Chemoradiotherapy for Unresectable Esophageal Cancer: Real-World Results. Life (Basel). 2022 May 8;12(5):706. doi: 10.3390/life12050706. (SCI; IF=3.817; BIOLOGY 27/93)
  • 3. Yang JCS, Wang YM, Wu SC, Lin WC, Chien PC, Tsai PY, Hsieh CH, Luo SD. Lymphaticovenous Anastomosis for Treating Secondary Lower Limb Lymphedema in Older Patients—A Retrospective Cohort Study. J Clin Med. 2022; 11(11):3089. (SCI; IF=4.242; MEDICINE, GENERAL & INTERNAL 39/167)
  • 4. Mito D, Wang YM, Wu SC, Lin WC, Tsai PY, Hsieh CH, Yang JC*. Use of Microscope-Integrated Near-Infrared Fluorescence for Enhancing Deep Lymphatic Vessel Detection during Supermicrosurgical Lymphaticovenous Anastomosis: A Longitudinal Cohort Study. Plast Reconstr Surg. 2022 May 1;149(5):1227-1233. (SCI; IF=4.763; SURGERY 28/211)
  • 5. Chou SY, Lu HI, Chen YH, Lo CM, Lin YH, Huang TT, Fang FM, Chen LC, Chen Y, Chiu YC, Chou YP, Li SH*, Wang YM*.: The Radiation Dose to the Left Supraclavicular Fossa is Critical for Anastomotic Leak Following Esophagectomy - A Dosimetric Outcome Analysis. Cancer Manag Res. 2022 May 2;14:1603-1613. (SCI; IF=3.989; ONCOLOGY 129/242)
  • 6. Chen YH, Chien CY, Wang YM, Li SH*. Serum Levels of Stromal Cell-Derived Factor-1α and Vascular Endothelial Growth Factor Predict Clinical Outcomes in Head and Neck Squamous Cell Carcinoma Patients Receiving TPF Induction Chemotherapy. Biomedicines. 2022 Mar 29; 10(4):803. (SCI; IF=6.081; PHARMACOLOGY & PHARMACY 33/276)
  • 7. Cheng YC, Wang YM, Lin YH, Cheng JY, Li SH, Huang YC, Tsai MY. Preventive effect and safety of Chinese herbal medicine for oral mucositis during radiotherapy in patients with head and neck cancer: Study protocol for a randomized trial. Contemp Clin Trials Commun. 2022 Mar 20;27:100912.
  • 8. Lee CL, Chen WS, Wee Y, Wang CS, Chen WC, Chiu TJ, Wang YM, Wu CN, Yang YH, Luo SD*, Wu SC*. Direct Oral Anticoagulants Are Associated with Superior Survival Outcomes than Warfarin in Patients with Head and Neck Cancers. Cancers (Basel). 2022 Jan 29;14(3):703. (SCI; IF=6.639; ONCOLOGY 51/242)
  • 9. Yang JC, Wu SC, Hayashi A, Lin WC, Wang YM, Luo SD, Chiang MH, Hsieh CH*. Selection of Optimal Functional Lymphatic Vessel Cutoff Size in Supermicrosurgical Lymphaticovenous Anastomosis in Lower Extremity Lymphedema. Plast Reconstr Surg. 2022 Jan 1;149(1):237-246. (SCI; IF=4.763; SURGERY 28/211)
  • 10. Lin YH, Huang SY, Chou SY, Huang TT, Wang YM*.: Dose Escalation or Not-Does Age Matter? J Clin Oncol. 2021 Dec 1;39(34):3881-3882. (SCI; IF=44.544; ONCOLOGY 4/242)
  • 11. Wang YM, Cheng JY, Wang CJ, Hseu SS, Huang EY*.: Outcomes and Prognosis of Non-Elderly Patients with Brain Metastases—A Prospective Cohort Incorporating Individualized Assessment of Heart Rate Variability. J Pers Med 2021, 11(11), 1049. (SCI; IF=4.945; HEALTH CARE SCIENCES & SERVICES 15/108)
  • 12. Wang YM, Chen YF, Lee PY, Ho MW*, Huang EY*.: Radiation-Induced Emesis (RIE) in Extended-Field Radiotherapy for Gynecological Malignancies: Dosimetric and Non-Dosimetric Factors. Curr Oncol. 2021 Sep 17;28(5):3602-3609. (SCI; IF=3.677; ONCOLOGY 142/242)
  • 13. Lin YH, Cheng JY, Huang BS, Luo SD, Lin WC, Chou SY, Juang PJ, Li SH, Huang EY, Wang YM*.: Significant Reduction in Vertebral Artery Dose by Intensity Modulated Proton Therapy: A Pilot Study for Nasopharyngeal Carcinoma. J Pers Med. 2021 Aug 22;11(8):822. (SCI; IF=4.945; HEALTH CARE SCIENCES & SERVICES 15/108)
  • 14. Chen WS, Luo SD, Chiu TJ, Wang YM, Chen WC, Chien CY, Fang FM, Huang TL, Li SH*.: Ribophorin II Overexpression Is Associated with Poor Response to Induction Chemotherapy with Docetaxel, Cisplatin, and Fluorouracil in P16-Negative Locally Advanced Head and Neck Squamous Cell Carcinoma. J Clin Med. 2021 Sep 12;10(18):4118. (SCI; IF=4.241; MEDICINE, GENERAL & INTERNAL 39/169)
  • 15. Chen YH, Lu HI, Wang YM, Lo CM, Chou SY, Li SH*,: SDF-1α predicts poor prognosis in patients with locally advanced esophageal squamous cell carcinoma receiving definitive concurrent chemoradiotherapy. Biomed J. 2021. https://doi.org/10.1016/j.bj.2021.05.004 (SCI; IF=4.910; BIOCHEMISTRY & MOLECULAR BIOLOGY 95/295)
  • 16. Liu CM, Huang BS, Yen YH, Wang YM, Huang EY, Hsu HC, Huang TT, Yang YH, Cheng JY*.: Concurrent Sorafenib and Radiotherapy versus Radiotherapy Alone for Locally Advanced Hepatocellular Carcinoma: A Propensity-Matched Analysis. J Hepatocell Carcinoma. 2021 Aug 18;8:963-973. (SCI; IF=5.828; ONCOLOGY 69/242)
  • 17. Li SH, Chen YH, Lu HI, Lo CM, Huang CC, Wang YM, Huang EY*.: Galectin-1 Expression Is Associated with the Response and Survival Following Preoperative Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma. Cancers (Basel). 2021 Jun 23;13(13):3147. (SCI; IF=6.639; ONCOLOGY 51/242)
  • 18. Huang TT, Li SH, Chen YH, Lu HI, Lo CM, Fang FM, Chou SY, Chiu YC, Chou YP, Wang YM*.: Definitive chemoradiotherapy for clinical T4b esophageal cancer - Treatment outcomes, failure patterns, and prognostic factors. Radiother Oncol. 2021 Apr;157:56-62. (SCI; IF=6.280; RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING 15/134)
  • 19. Wang YM, Hsieh YW, Huang BS, Sung KC, Juan KJ, Lee SP, Lee SH*, Huang EY*.: Medical Mask Wearing During Treatment for Patients Undergoing Radiotherapy in COVID-19 Pandemic - An Experience of Protocol Setup and Dosimetric Evaluation for Particle/Proton Beam Therapy. Risk Manag Healthc Policy. 2021 Mar 2;14:869-873. (SCI; IF=3.200; HEALTH POLICY & SERVICES 25/88, co-first author)
  • 20. Lo CM, Wang YM, Chen YH, Fang FM, Huang SC, Lu HI, Li SH*.: The Impact of Radiotherapy Dose in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Preoperative Chemoradiotherapy. Curr Oncol. 2021 Mar 29;28(2):1354-1365. (SCI; IF=3.677; ONCOLOGY 142/242)
  • 21. Huang EY, Wang YM, Chang SC, Liu SY, Chou MC*.: Rectal Dose Is the Other Dosimetric Factor in Addition to Small Bowel for Prediction of Acute Diarrhea during Postoperative Whole-Pelvic Intensity-Modulated Radiotherapy in Gynecologic Patients. Cancers (Basel). 2021 Jan 28;13(3):497. (SCI; IF=6.639; ONCOLOGY 51/242; Co-first author)
  • 22. Cheng JY, Liu CM, Wang YM, Hsu HC, Huang EY, Huang TT, Lee CH, Hung SP, Huang BS*.: Proton versus photon radiotherapy for primary hepatocellular carcinoma: a propensity-matched analysis. Radiat Oncol. 2020 Jun 30;15(1):159. (SCI; IF = 3.481; RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING 50/134)
  • 23. Luo SD, Chen WC, Wu CN, Yang YH, Li SH, Fang FM, Huang TL, Wang YM, Chiu TJ*, Wu SC*.: Low-Dose Aspirin Use Significantly Improves the Survival of Late-stage NPC: A Propensity Score-Matched Cohort Study in Taiwan. Cancers (Basel). 2020 Jun 12;12(6):1551. (SCI; IF=6.639; ONCOLOGY 51/242)
  • 24. Chen YH, Lu HI, Chien CY, Lo CM, Wang YM, Chou SY, Li SH*.: Efficacy of Different Chemotherapy Regimens in Patients with Locally Advanced Synchronous Esophageal and Head/Neck Squamous Cell Carcinoma Receiving Curative Concurrent Chemoradiotherapy. J Clin Med. 2020 Jan 10;9(1):197. (SCI; IF=4.241; MEDICINE, GENERAL & INTERNAL 39/169)
  • 25. Chen CS, Ou YC, Lin H, Wang CJ, Chen HC, Fang FM, Hsu HC, Huang YJ, Wang YM, Huang CC, Chou SY, Cheng JY, Huang EY*.: Analysis of prognostic factors and clinical outcomes in uterine cervical carcinoma with isolated para-aortic lymph node recurrence. Am J Transl Res. 2019 Dec 15;11(12):7492-7502. (SCI; IF=4.060; MEDICINE, RESEARCH & EXPERIMENTAL 70/140)
  • 26. Chen LC, Li SH, Lo CM, Chen YH, Huang SC, Wang YM, Chou SY, Lu HI*.: Platelet-to-lymphocyte ratio is an independent prognosticator in patients with esophageal squamous cell carcinoma receiving esophagectomy. J Thorac Dis. 2019 Nov;11(11):4583-4590. (SCI; IF=2.895; RESPIRATORY SYSTEM 38/64)
  • 27. Huang WT, Lu HI, Wang YM, Chen YH, Lo CM, Lin WC, Lan YC, Tseng LH, Li SH*.: Positive Programmed Cell Death-Ligand 1 Expression Predicts Poor Treatment Outcomes in Esophageal Squamous Cell Carcinoma Patients Receiving Neoadjuvant Chemoradiotherapy. J Clin Med. 2019 Nov 3;8(11):1864. (SCI; IF=4.241; MEDICINE, GENERAL & INTERNAL 39/169)
  • 28. Chen YH, Lu HI, Lo CM, Wang YM, Chou SY, Hsiao CC, Li SH*.: The Clinical Outcomes of Locally Advanced Cervical Esophageal Squamous Cell Carcinoma Patients Receiving Curative Concurrent Chemoradiotherapy: A Population-Based Propensity Score-Matched Analysis. Cancers (Basel). 2019 Mar 30;11(4):451. (SCI; IF=6.639; ONCOLOGY 51/242)
  • 29. Huang YC, Li SH, Lu HI, Hsu CC, Wang YM, Lin WC, Chen CJ, Ho KW, Chiu NT*.: Post-chemoradiotherapy FDG PET with qualitative interpretation criteria for outcome stratification in esophageal squamous cell carcinoma. PLoS One. 2019 Jan 7;14(1):e0210055. (SCI; IF = 3.240; MULTIDISCIPLINARY SCIENCES 26/72)
  • 30. Chen YH, Lu HI, Lo CM, Wang YM, Chou SY, Hsiao CC, Shih LH, Chen SW, Li SH*.: Neck Lymph Node Metastasis as A Poor Prognostic Factor in Thoracic Esophageal Squamous Cell Carcinoma Patients Receiving Concurrent Chemoradiotherapy: A Propensity Score-Matched Analysis. Sci Rep. 2018 Oct 10;8(1):15073 (SCI; IF = 4.379; MULTIDISCIPLINARY SCIENCES 17/72)
  • 31. Wu CC, Li SH, Lu HI, Lo CM, Wang YM, Chou SY, Chen YH*.: Inflammation-based prognostic scores predict the prognosis of locally advanced cervical esophageal squamous cell carcinoma patients receiving curative concurrent chemoradiotherapy: a propensity score-matched analysis. PeerJ. 2018 Sep 19;6:e5655. doi: 10.7717/peerj.5655. (SCI; IF = 2.984; MULTIDISCIPLINARY SCIENCES 27/72)
  • 32. Chen YH, Lu HI, Lo CM, Wang YM, Chou SY, Hsiao CC, Huang CC, Shih LH, Chen SW, Li SH*.: The crucial role of blood VEGF kinetics in patients with locally advanced esophageal squamous cell carcinoma receiving curative concurrent chemoradiotherapy. BMC Cancer. 2018 Aug 20;18(1):837. (SCI; IF = 4.430; ONCOLOGY 110/242)
  • 33. Hsiao YT, Li SH, Wang YM, Kuo HK*.: Successful outcome after radiotherapy in esophageal squamous cell carcinoma with choroidal metastasis: A case report and review of literature. Indian J Ophthalmol. 2018 Aug;66(8):1215-1217. (SCI; IF = 1.848; OPHTHALMOLOGY 48/62)
  • 34. Chen YH, Lu HI, Lo CM, Wang YM, Chou SY, Huang CH, Shih LH, Chen SW, Li SH*.: The clinical impact of supraclavicular lymph node metastasis in patients with locally advanced esophageal squamous cell carcinoma receiving curative concurrent chemoradiotherapy. PLoS One. 2018 Jun 11;13(6):e0198800. (SCI; IF = 3.240; MULTIDISCIPLINARY SCIENCES 26/72)
  • 35. Chiu TJ, Lu HI, Chen CH, Huang WT, Wang YM, Lin WC, Li SH*.: Osteopontin Expression Is Associated with the Poor Prognosis in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Preoperative Chemoradiotherapy. Biomed Res Int. 2018 Apr 30;2018:9098215. (SCI; IF = 3.411; BIOTECHNOLOGY & APPLIED MICROBIOLOGY 69/159)
  • 36. Lin YH, Huang TL, Chien CY, Chen HC, Hsu HC, Huang EY, Wang CJ, Huang YJ, Wang YM, Huang CC, Chou SY, Liao KC, Fang FM*.: Pretreatment prognostic factors of survival and late toxicities for patients with nasopharyngeal carcinoma treated by simultaneous integrated boost intensity-modulated radiotherapy. Radiat Oncol. 2018 Mar 20;13(1):45. (SCI; IF = 3.481; RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING 50/134)
  • 37. Chen YH, Lu HI, Wang YM, Lo CM, Chou SY, Huang CH, Shih LH, Chen SW, Li SH*.: The prognostic significance of celiac lymph node metastasis in patients with locally advanced esophageal squamous cell carcinoma receiving curative concurrent chemoradiotherapy. Oncotarget. 2017 Oct 16;8(56):96190-96202.
  • 38. Wang YM, Wang CJ, Fang FM, Chen HC, Hsu HC, Huang YJ, Wang CY, Huang EY*: Differences in the outcomes and complications between elderly and younger uterine cervical cancer patients treated by definitive radiotherapy - A propensity score-matched study, Gynecol Oncol. 2017 May;145(2):277-283. (SCI; IF = 5.482; OBSTETRICS & GYNECOLOGY 8/83)
  • 39. Chen CH, Lu HI, Wang YM, Chen YH, Lo CM, Huang WT, Li SH*: Areca nut is associated with younger age of diagnosis, poor chemoradiotherapy response, and shorter overall survival in esophageal squamous cell carcinoma. PLoS One. 2017 Feb 28;12(2):e0172752.(SCI; IF = 3.240; MULTIDISCIPLINARY SCIENCES 26/72)
  • 40. Chen YH, Lu HI, Chien CY, Lo CM, Wang YM, Chou SY, Su YY, Shih LH, Li SH*: Treatment Outcomes of Patients with Locally Advanced Synchronous Esophageal and Head/Neck Squamous Cell Carcinoma Receiving Curative Concurrent Chemoradiotherapy. Sci Rep. 2017 Jan 30;7:41785. (SCI; IF = 4.379; MULTIDISCIPLINARY SCIENCES 17/73)
  • 41. Huang YC, Lu HI, Huang SC, Hsu CC, Chiu NT, Wang YM, Chiu YC, Li SH*: FDG PET using SUVmax for preoperative T-staging of esophageal squamous cell carcinoma with and without neoadjuvant chemoradiotherapy. BMC Med Imaging. 2017 Jan 5;17(1):1. (SCI; IF = 1.930; RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING 99/134)
  • 42. Wang YM, Cheng JY, Ting HM, Lee TH*: Treatment Outcomes of Radiotherapy for Primary Intracranial Osteosarcoma. Therapeut Radiol Oncol 2016; 23(4): 285-290
  • 43. Tsai SH, Huang YY, Tse CK, Chen YJ, Juan KJ, Huang EY, Wang YM*: Evaluating Planning Target Volume Margin of Active Breathing Control-Gated Radiotherapy by Using Image-Guidance System. Chi J Radiologic Tech. 2016; 40(1): 8-14
  • 44. Lo YC, Wang YM, Huang CC, Wang CJ, Fang FM, Hsu HC, Huang EY, Huang YJ, Chen HC.: A single institute's experience with radiation therapy for adenoid cystic carcinoma arising from the respiratory tract. Therapeut Radiol Oncol 2015; 22(3): 163-170
  • 45. Lu HI, Li SH*, Huang WT, Rau KM, Fang FM, Wang YM, Lin WC, Tien WY.: A comparative study of isolated and metachronous oesophageal squamous cell carcinoma with antecedent upper aerodigestive tract cancer. Eur J Cardiothorac Surg. 2013 Nov;44(5):860-5. SCI; IF = 4.191; Surgery 39/212)
  • 46. Wang YM, Wu HT, Huang EY, Kou YR*, Hseu SS*: Heart Rate Variability is Associated with Survival in Patients with Brain Metastasis - A Preliminary Report. Biomed Res Int. 2013; 2013:503421. doi: 10.1155/2013/503421. (SCI; IF = 3.411; Biotechnology & Applied Microbiology 69/159)
  • 47. Lu HI, Li SH, Huang WT, Rau KM, Fang FM, Wang YM, Lin WC, Tien WY.: A comparative study of isolated and metachronous oesophageal squamous cell carcinoma with antecedent upper aerodigestive tract cancer. Eur J Cardiothorac Surg. 2013 Nov;44(5):860-5. (SCI; IF = 4.191; Surgery 39/212)
  • 48. Hsu CM, Lin PM, Wang YM, Chen ZJ, Lin SF*, Yang MY*.: Circulating miRNA is a novel marker for head and neck squamous cell carcinoma. Tumor Biol. 2012 Dec;33(6):1933-42. (SCI; IF = 3.650; Oncology 81/217)
  • 49. Li SH, Rau KM, Lu HI, Wang YM, Tien WY, Liang JL, Lin WC*.: Pre-treatment maximal oesophageal wall thickness is independently associated with response to chemoradiotherapy in patients with T3-4 oesophageal squamous cell carcinoma. Eur J Cardiothorac Surg. 2012 Dec;42(6):958-64. (SCI; IF = 4.191; Surgery 39/212)
  • 50. Wang YM, Huang CC, Ting HM, Wang CJ*.: Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced anaplastic thyroid cancer. Therapeut Radiol Oncol 2012; 19(2): 153-159
  • 51. Hsu HC, Chen HH, Chang CL, Fang FM, Wang CJ, Chen HC, Huang YJ, Wang CY, Wang YM, Huang EY*.: Postoperative Low Pelvic Radiotherapy and Chemotherapy for Stage II and III Rectal Cancer. Am J Clin Oncol. 2012 Feb;35(1):68-72. (SCI; IF = 2.339; Oncology 215/242)
  • 52. Chen YH, Lu HI, Huang CH, Rau KM, Chiu YC, Wang YM, Chen YY, Liu CT, Li SH*.: Trimodality Treatment for Locally Advanced, Resectable Esophageal Squamous Cell Carcinoma. J Cli Res Prac. 2011; 27(5):200-210.
  • 53. Huang CC, Huang EY, Fang FM, Wang CJ, Chen HC, Huang YJ, Wang CY, Wang YM, Hsu HC*: Three-Dimentional Conformal Radiotherapy for Unresectable or Post-Operative Residual Biliary Tract Carcinoma. Therapeut Radiol Oncol 2011; 18(2): 97-110
  • 54. Huang EY, Hsu HC, Sun LM, Chanchien CC, Lin H, Chen HC, Tseng CW, Ou YC, Chang HY, Fang FM, Huang YJ, Wang CY, Lu HM, Tsai CC, Ma YY, Fu HC, Wang YM, Wang CJ*: Prognostic Value of Pretreatment Carcinoembryonic Antigen After Definitive Radiotherapy With or Without Concurrent Chemotherapy for Squamous Cell Carcinoma of the Uterine Cervix. Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):1105-13. (SCI; IF = 7.038; Radiology 11/134)
  • 55. Huang EY*, Wang CJ, Lan JH, Chen HC, Fang FM, Hsu HC, Huang YJ, Wang CY, Wang YM.: Factors for Predicting Rectal Dose of High-Dose-Rate Intracavitary Brachytherapy After Pelvic Irradiation in Patients with Cervical Cancer: A Retrospective Study with Radiography-Based Dosimetry. Int J Radiat Oncol Biol Phys. 2010 Feb 1;76(2):490-5 (SCI; IF = 7.038; Radiology 11/134)
  • 56. Fang FM, Wang YM, Wang CJ, Huang HY, Chiang PH*.: Comparison of the outcome and morbidity for localized or locally advanced prostate cancer treated by high-dose-rate brachytherapy plus external beam radiotherapy (EBRT) versus EBRT alone. Jpn J Clin Oncol. 2008 Jul;38(7):474-9 (SCI; IF = 3.019; Oncology 180/242)
  • 57. Wang YM, Wang CJ*, Huang EY, Chen HC, Sun LM, Fang FM, Hsu HC, Hsiung CY, Huang YJ, Wang CY.: Treatment results and prognostic factors of esthesioneuroblastoma (ENB). Therapeut Radiol Oncol 2005; 12(3): 191-198
論文著述(共同作者)
  • 學術論文與會議發表逾40篇
醫學會議
  • 專題演講與論文發表逾30篇
獎勵與榮譽
  • 2008 放射腫瘤專科醫師考試 第一名
  • 2014 高雄長庚紀念醫院 優良臨床教師
  • 2015 第20屆台灣聯合癌症年會暨第14屆海峽兩岸腫瘤學術大會 臨床研究獎
  • 2015 國家實驗研究院Stanford-Taiwan Biomedical (STB)學者
  • 2015 美國Stanford大學 公派獎學金
  • 2018 高雄長庚紀念醫院 最佳臨床教師
  • 2019 第24屆台灣聯合癌症年會 臨床研究獎第二名